Greenway Greenhouse Cannabis Corporation Reports Strong Year-End Financial Performance with Record Revenue Growth
Greenway Greenhouse Cannabis Corporation's Financial Highlights
Greenway Greenhouse Cannabis Corporation, a leading Canadian cultivator in the cannabis market, recently released its audited financial results for the year ending March 31, 2026. The company has shown significant financial resilience and adaptability in a rapidly changing market.
Strong Revenue Performance
During the fiscal year 2026, Greenway reported a net revenue of $7.4 million, demonstrating adaptability despite an overall decrease compared to last year's revenue of $8.9 million. The adjustment in revenue largely stemmed from lower sales volumes; however, the average selling price per gram saw a notable increase of 21%, reaching $1.60. This strategic pricing adjustment reflects ongoing shifts in market demand and the company's robust positioning within the high-value segments of both domestic and international cannabis markets.
Impressive Profitability Metrics
An essential indicator of Greenway's operational efficiency, the adjusted EBITDA rose to $1.1 million, marking the second consecutive year of positive EBITDA. This achievement underscores the company's commitment to enhance profitability despite facing challenging market conditions. The gross margin, before any adjustments, improved significantly to 29%, up from 18% in the previous year.
Expansion into International Markets
Notably, Greenway's efforts to penetrate international markets are yielding impressive results. In the fourth quarter alone, sales of cannabis flower destined for export comprised approximately 50% of total flower sales. This growth trajectory is a testament to Greenway's strategic partnerships with domestic companies facilitating exports to international medical cannabis markets.
Strategic Initiatives for Growth
CEO Jamie D'Alimonte expressed optimism regarding Greenway's future, stating that fiscal 2026 marked a pivotal transition toward focusing on higher-value markets. In a bid to optimize operations and improve financial positioning, the company has adopted a conservative approach by reevaluating legacy inventory. This proactive measure involved recognizing a one-time non-cash inventory impairment of approximately $1.1 million, primarily arising from products that no longer align with Greenway's forward-looking production strategy.
Continued Commitment to Premium Products
Greenway's strategy moving forward includes an intensified focus on high-quality cultivars with favorable long-term pricing characteristics. Management emphasizes maintaining operational efficiencies and disciplined cost controls as integral components of their growth strategy while reinforcing relationships with both domestic and international partners.
Looking Forward
As Greenway heads into fiscal 2027, the management team is optimistic about future growth opportunities fueled by ongoing demand in international cannabis markets. Enhancing product offerings and focusing resources on premium cultivars will be key components of their operational strategy.
In conclusion, Greenway Greenhouse Cannabis Corporation’s year-end financial results illustrate a robust framework for sustainable growth and profitability in the evolving cannabis landscape. The company’s strategic initiatives are poised to create significant long-term value for shareholders while maintaining a commitment to quality and operational excellence.
For further details, Greenway's audited financial statements for the year ending March 31, 2026, are available on their profile at www.sedarplus.ca.